Current and historical daily PE Ratio for Sesen Bio Inc (
FRA:PCBK
) from 2016 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sesen Bio stock (FRA:PCBK) PE ratio as of Jun 21 2024 is 0.
More Details
Sesen Bio Inc (FRA:PCBK) PE Ratio (TTM) Chart
Sesen Bio Inc (FRA:PCBK) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 964
- 1
- 2
- 3
- 4
- 5
- 6
- 11
Sesen Bio PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-21 | At Loss | 2023-01-04 | At Loss |
2023-03-07 | At Loss | 2023-01-03 | At Loss |
2023-03-06 | At Loss | 2023-01-02 | At Loss |
2023-03-03 | At Loss | 2022-12-30 | At Loss |
2023-03-02 | At Loss | 2022-12-29 | At Loss |
2023-03-01 | At Loss | 2022-12-28 | At Loss |
2023-02-28 | At Loss | 2022-12-27 | At Loss |
2023-02-27 | At Loss | 2022-12-26 | At Loss |
2023-02-24 | At Loss | 2022-12-23 | At Loss |
2023-02-23 | At Loss | 2022-12-22 | At Loss |
2023-02-22 | At Loss | 2022-12-21 | At Loss |
2023-02-21 | At Loss | 2022-12-20 | At Loss |
2023-02-20 | At Loss | 2022-12-19 | At Loss |
2023-02-17 | At Loss | 2022-12-16 | At Loss |
2023-02-16 | At Loss | 2022-12-15 | At Loss |
2023-02-15 | At Loss | 2022-12-14 | At Loss |
2023-02-14 | At Loss | 2022-12-13 | At Loss |
2023-02-13 | At Loss | 2022-12-12 | At Loss |
2023-02-10 | At Loss | 2022-12-09 | At Loss |
2023-02-09 | At Loss | 2022-12-08 | At Loss |
2023-02-08 | At Loss | 2022-12-07 | At Loss |
2023-02-07 | At Loss | 2022-12-06 | At Loss |
2023-02-06 | At Loss | 2022-12-05 | At Loss |
2023-02-03 | At Loss | 2022-12-02 | At Loss |
2023-02-02 | At Loss | 2022-12-01 | At Loss |
2023-02-01 | At Loss | 2022-11-30 | At Loss |
2023-01-31 | At Loss | 2022-11-29 | At Loss |
2023-01-30 | At Loss | 2022-11-28 | At Loss |
2023-01-27 | At Loss | 2022-11-25 | At Loss |
2023-01-26 | At Loss | 2022-11-24 | At Loss |
2023-01-25 | At Loss | 2022-11-23 | At Loss |
2023-01-24 | At Loss | 2022-11-22 | At Loss |
2023-01-23 | At Loss | 2022-11-21 | At Loss |
2023-01-20 | At Loss | 2022-11-18 | At Loss |
2023-01-19 | At Loss | 2022-11-17 | At Loss |
2023-01-18 | At Loss | 2022-11-16 | At Loss |
2023-01-17 | At Loss | 2022-11-15 | At Loss |
2023-01-16 | At Loss | 2022-11-14 | At Loss |
2023-01-13 | At Loss | 2022-11-11 | At Loss |
2023-01-12 | At Loss | 2022-11-10 | At Loss |
2023-01-11 | At Loss | 2022-11-09 | At Loss |
2023-01-10 | At Loss | 2022-11-08 | At Loss |
2023-01-09 | At Loss | 2022-11-07 | At Loss |
2023-01-06 | At Loss | 2022-11-04 | At Loss |
2023-01-05 | At Loss | 2022-11-03 | At Loss |
Sesen Bio Inc (FRA:PCBK) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Sesen Bio Inc Sesen Bio Inc logo](https://static.gurufocus.com/logos/0C0000AJRO.png?14)
Sesen Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US8177631053
Compare
Compare
Traded in other countries / regions
PCBK.Germany IPO Date
2016-04-22Description
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG.